These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 7933620

  • 21. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity.
    Yosipovitch G, Shohat B, Bshara J, Wysenbeek A, Weinberger A.
    Isr J Med Sci; 1995 Jun; 31(6):345-8. PubMed ID: 7607852
    [Abstract] [Full Text] [Related]

  • 22. Soluble interleukin-2 receptor in juvenile rheumatoid arthritis.
    Silverman ED, Laxer RM, Nelson DL, Rubin LA.
    J Rheumatol; 1991 Sep; 18(9):1398-402. PubMed ID: 1757944
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage.
    Schmitt WH, Csernok E, Kobayashi S, Klinkenborg A, Reinhold-Keller E, Gross WL.
    Arthritis Rheum; 1998 Mar; 41(3):445-52. PubMed ID: 9506572
    [Abstract] [Full Text] [Related]

  • 29. [The soluble IL-2 receptor in malignant hemopathies].
    Rupoli S, Montillo M, Salvi A, Brianzoni MF, Centurioni R, Cinciripini A, Paoletti P, Recchioni A, Leoni P.
    Recenti Prog Med; 1992 Oct; 83(10):546-51. PubMed ID: 1462037
    [Abstract] [Full Text] [Related]

  • 30. Prognostic value of serum biological markers in patients with hepatocellular carcinoma.
    Parasole R, Izzo F, Perrone F, Pignata S, Galati MG, Leonardi E, Castiglione F, Orlando R, Castello G, Esposito G, Gallo C, Daniele B.
    Clin Cancer Res; 2001 Nov; 7(11):3504-9. PubMed ID: 11705869
    [Abstract] [Full Text] [Related]

  • 31. Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.
    Lauerová L, Dusek L, Simícková M, Rovný F, Spurný V, Rovný A, Slampa P, Zaloudík J, Rejthar A, Wotke J, Kovarík J.
    Neoplasma; 1999 Nov; 46(3):141-9. PubMed ID: 10613588
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Evaluation of interleukin-2 soluble receptor in patients with trypanosomiasis americana in Panama].
    Pascale JM, Sosa CE, Orn A.
    Rev Med Panama; 1991 Sep; 16(3):184-8. PubMed ID: 1767036
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [The changes of soluble interleukin-2 receptor in serum and cerebrospinal fluid of patients with delayed encephalopathy after acute carbon monoxide poisoning].
    Gu R, Zhang X, Lu L, Lu H, Song J, Guo X, Zhang Z, Liu M.
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2002 Oct; 20(5):350-2. PubMed ID: 14694723
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Serum levels of tumor necrosis factor and soluble interleukin 2 receptor as markers of disease activity and prognosis in childhood leukemia and lymphoma.
    Kalmanti M, Karamolengou K, Dimitriou H, Tosca A, Vlachonikolis I, Peraki M, Georgoulias V, Kalmantis T.
    Int J Hematol; 1993 Apr; 57(2):147-52. PubMed ID: 8494993
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Soluble interleukin 2 receptor (sIL-2R) levels in renal transplant recipients.
    Mehta R, Shah G, Adler W, Kittur D.
    Clin Transplant; 2004 Apr; 18 Suppl 12():67-71. PubMed ID: 15217411
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.